New Perspective in Atrial Fibrillation
In spite of the large volume of associated research, the pathophysiological mechanisms involved in atrial fibrillation (AF) onset and recurrence remain uncertain. This may explain why the performances of thromboembolic and bleeding prediction scores in AF patients are limited. In the past few years,...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 electronic resource (224 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993546248504498 |
---|---|
ctrlnum |
(CKB)5400000000044484 (oapen)https://directory.doabooks.org/handle/20.500.12854/76719 (EXLCZ)995400000000044484 |
collection |
bib_alma |
record_format |
marc |
spelling |
Guenancia, Charles edt New Perspective in Atrial Fibrillation Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 1 electronic resource (224 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier In spite of the large volume of associated research, the pathophysiological mechanisms involved in atrial fibrillation (AF) onset and recurrence remain uncertain. This may explain why the performances of thromboembolic and bleeding prediction scores in AF patients are limited. In the past few years, the concept of atrial cardiopathy has emerged as a promising lead to connect AF to stroke, heart failure, and inflammatory processes: indeed, all of the mechanisms associated with atrial remodeling and the development of atrial cardiopathy are also likely to promote the development of AF. This recent concept of atrial cardiopathy suggests that the real trigger of stroke may be an abnormal atrial substrate rather than atrial rhythm itself. In this setting, AF could be seen as a symptom of atrial cardiopathy rather than a risk factor of stroke. In the absence of validated clinical markers of atrial cardiopathy, the search for the mechanism of AF remains the cornerstone of cardioembolic stroke prevention for now.The aim of this Special Issue is to gather basic research as well as pathophysiological and epidemiological papers focused on the relationship between atrial substrates and atrial fibrillation onset, recurrence, and outcomes. English Medicine bicssc postoperative atrial fibrillation biomarkers coronary artery bypass grafting miRNA circRNA mtDNA SNPs atrial fibrillation acute myocardial infarction heart rate variability autonomic nervous system bleeding risk age left atrial appendage closure coronary artery disease prognosis anticoagulation antiplatelet therapy hypertension elderly prevention ganglionated plexi ablation dementia early-onset ischemic stroke risk factor new oral anticoagulants mitochondria cardiac remodeling pharmacotherapy electroporation pulsed field ablation cardiac heart arrhythmia NOAC VKA statin outcome mortality paroxysmal atrial fibrillation catheter ablation epicardial adipose tissue persistent atrial fibrillation posterior wall hybrid ablation convergent ablation atrial tachycardia mechanism spatiotemporal dispersion left atrial appendage occlusion BNP atrial remodeling atrial cardiopathy cardiac ablation irreversible electroporation 3-0365-1822-3 3-0365-1821-5 Guenancia, Charles oth |
language |
English |
format |
eBook |
author2 |
Guenancia, Charles |
author_facet |
Guenancia, Charles |
author2_variant |
c g cg |
author2_role |
Sonstige |
title |
New Perspective in Atrial Fibrillation |
spellingShingle |
New Perspective in Atrial Fibrillation |
title_full |
New Perspective in Atrial Fibrillation |
title_fullStr |
New Perspective in Atrial Fibrillation |
title_full_unstemmed |
New Perspective in Atrial Fibrillation |
title_auth |
New Perspective in Atrial Fibrillation |
title_new |
New Perspective in Atrial Fibrillation |
title_sort |
new perspective in atrial fibrillation |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2021 |
physical |
1 electronic resource (224 p.) |
isbn |
3-0365-1822-3 3-0365-1821-5 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT guenanciacharles newperspectiveinatrialfibrillation |
status_str |
n |
ids_txt_mv |
(CKB)5400000000044484 (oapen)https://directory.doabooks.org/handle/20.500.12854/76719 (EXLCZ)995400000000044484 |
carrierType_str_mv |
cr |
is_hierarchy_title |
New Perspective in Atrial Fibrillation |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796651990468526080 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03975nam-a2200973z--4500</leader><controlfield tag="001">993546248504498</controlfield><controlfield tag="005">20231214133239.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202201s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044484</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/76719</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044484</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Guenancia, Charles</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New Perspective in Atrial Fibrillation</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (224 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In spite of the large volume of associated research, the pathophysiological mechanisms involved in atrial fibrillation (AF) onset and recurrence remain uncertain. This may explain why the performances of thromboembolic and bleeding prediction scores in AF patients are limited. In the past few years, the concept of atrial cardiopathy has emerged as a promising lead to connect AF to stroke, heart failure, and inflammatory processes: indeed, all of the mechanisms associated with atrial remodeling and the development of atrial cardiopathy are also likely to promote the development of AF. This recent concept of atrial cardiopathy suggests that the real trigger of stroke may be an abnormal atrial substrate rather than atrial rhythm itself. In this setting, AF could be seen as a symptom of atrial cardiopathy rather than a risk factor of stroke. In the absence of validated clinical markers of atrial cardiopathy, the search for the mechanism of AF remains the cornerstone of cardioembolic stroke prevention for now.The aim of this Special Issue is to gather basic research as well as pathophysiological and epidemiological papers focused on the relationship between atrial substrates and atrial fibrillation onset, recurrence, and outcomes.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">postoperative atrial fibrillation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">coronary artery bypass grafting</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mtDNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SNPs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atrial fibrillation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acute myocardial infarction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heart rate variability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autonomic nervous system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bleeding risk</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">age</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">left atrial appendage closure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">coronary artery disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anticoagulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiplatelet therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypertension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">elderly</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prevention</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ganglionated plexi</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dementia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">early-onset</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ischemic stroke</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">risk factor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">new oral anticoagulants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mitochondria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiac remodeling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">electroporation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pulsed field ablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiac</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heart</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arrhythmia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NOAC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VKA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">statin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">outcome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mortality</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">paroxysmal atrial fibrillation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">catheter ablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epicardial adipose tissue</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">persistent atrial fibrillation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">posterior wall</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hybrid ablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">convergent ablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atrial tachycardia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mechanism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spatiotemporal dispersion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">left atrial appendage occlusion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BNP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atrial remodeling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atrial cardiopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiac ablation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">irreversible electroporation</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-1822-3</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-1821-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guenancia, Charles</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:47:43 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338167140004498&Force_direct=true</subfield><subfield code="Z">5338167140004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338167140004498</subfield></datafield></record></collection> |